Jonathan Behr
Board director at Quralis
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Jonathan
556 people in our graph share verified history with Jonathan — schools, employers, funds. One of them is your warm intro.
Kyle DohertyunlockedJonathan: together at Massachusetts Institute of Technology (2002–2004)
×4Jonathan: together at Massachusetts Institute of Technology
×3Jonathan: together at National Institutes of Health, NICHD, Laboratory of Integrative an
Jonathan: together at Nitrase Therapeutics
About
Jonathan Behr is a biotech investor and company builder with 20 years of experience in venture capital and therapeutics development. He has raised and co-led two venture fund strategies, led over 15 investments, served as investor representative on 14 boards, built 7 new companies, and achieved 7 exits. He currently serves as Fox Advisor and co-chair of the Targets to Therapies Initiative NOD2 at The Michael J. Fox Foundation for Parkinson's Research.
Board director at Quralis
Intro paths
→
In turn, Jonathan can intro founders to Quralis's investors below.
Quralis's investors · 14
Amgen VenturesThousand Oaks · $1M – $3M checks · since 2023Dementia Discovery FundLondon · since 2023Dolby Family VenturesSan Francisco · since 2023Droia VenturesLeuven · $540K checks · since 2025EQT Life SciencesLuxembourg · $11M – $66M checks · since 2023InkefAmsterdam · since 2023MC Healthcare VenturesCambridgeMission Bay CapitalSan Francisco · since 2023Mission BiocapitalSan Francisco · $500K checks · since 2025Mitsui Global InvestmentMenlo Park · $500K – $10M checks · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2025Sanofi VenturesCambridge · $5M checks · since 2023SV Health InvestorsBoston · $1M – $20M checksSynconaLondon · since 2022
Co-founders at Quralis
KE
Kevin EgganCo-founder
R
RoetCo-founder
W
WoolfCo-founder
KR
Kasper RoetDirector, Executive Officer, Promoter
Experience
- The Michael J. Fox Foundation for Parkinson's ResearchFox Advisor and Targets to Therapies Initiative NOD2 Co-chaircurrent2024 — present
- Parkinson's UKIndependent Director, Parkinson's Research Ventures Ltd.current2023 — presentLondon, England, United Kingdom
- Dementia Discovery FundPartner2019 — 2026Greater Boston
- SV Health InvestorsPartner2019 — 2026Boston, MA
- Sudo BiosciencesBoard Observer2024 — 2026
- Montara Therapeutics, Inc.Board Observer2024 — 2026
- Violet TherapeuticsMember Board of Directors2023 — 2026Cambridge, MA
- Transposon Therapeutics, Inc.Board Observer2022 — 2026
- QurAlisBoard Observer2022 — 2026
- QurAlisMember Board of Directors2020 — 2022
- Nitrase TherapeuticsMember Board of Directors2020 — 2026
- Ribometrix Inc.Board Observer2022 — 2025
- Caraway Therapeutics, Inc.Member Board of Directors2020 — 2023Cambridge, Massachusetts, United States
- JDRF T1D FundManaging Director2016 — 2019Greater Boston Area
- Inversago PharmaBoard Observer2018 — 2019
- Enthera PharmaceuticalsBoard Observer2018 — 2019
- ImmusanTBoard Observer2018 — 2019
- Diasome Pharmaceuticals, Inc.Board Observer2017 — 2019
- SQZ BiotechnologiesAdvisory Committee Member and Investor2017 — 2019
- Provention Bio, a Sanofi CompanyBoard Observer2017 — 2018
- Semma TherapeuticsBoard Observer2017
- AnTolRxBoard Observer2016Greater Boston Area
- Exosome DiagnosticsBoard Observer2015 — 2016
- Partners HealthCare (now Mass General Brigham)Executive in Residence and Market Sector Leader2013 — 2016Greater Boston Area
- Tilos TherapeuticsCo-founder2015 — 2016Greater Boston Area
- Entrega Inc.Member Board Of Directors2013 — 2015Boston
- Entrega, Inc.Chief Operating Officer, Co-founder2012 — 2013Boston
- Vedanta Biosciences, Inc.Co-founder2012 — 2013Boston
- MandaraCo-founder2012 — 2013
- Tal MedicalCo-founder2012 — 2013Boston
- Enlight BiosciencesVice President of New Ventures2011 — 2013Boston
- Enlight BiosciencesCo-founder2007 — 2011
- PureTech VenturesPrincipal2006 — 2011Boston
- Endra IncCo-founder2006 — 2011
- Solace Pharmaceuticals (UK) Ltd.Member Board Of Directors2010Boston
- Houston Methodist, The Arthritis Institute, Institute of Orthopedic Research andResearch Engineer2001 — 2002
- National Institutes of Health, NICHD, Laboratory of Integrative anWhitaker Biomedical Engineering BESIP Program2001
Skills & more
Board LevelDirector levelVenture CapitalNew Venture DevelopmentVenture ManagementDeal SourcingTechnology EvaluationLicensingBusiness StrategyBioengineeringBiotechnologyBiotechnology Industry
+12 more
Start-up VenturesStart-upsBusiness DevelopmentNew Business DevelopmentLifesciencesIntellectual PropertyDrug DiscoveryTechnology TransferStrategyManagementPharmaceutical IndustryMedical DevicesFrom Jonathan's professional profile.
Frequently asked questions
- Who is Jonathan Behr?
- Jonathan Behr is a biotech investor and company builder with 20 years of experience in venture capital and therapeutics development. He has raised and co-led two venture fund strategies, led over 15 investments, served as investor representative on 14 boards, built 7 new companies, and achieved 7 exits. He currently serves as Fox Advisor and co-chair of the Targets to Therapies Initiative NOD2 at The Michael J. Fox Foundation for Parkinson's Research.
- Where does Jonathan Behr work?
- Jonathan Behr is Board director at Quralis.
- What check size does Jonathan Behr write?
- Jonathan Behr typically writes checks of $100K – $5M.
- Where did Jonathan Behr go to school?
- Jonathan Behr studied at Massachusetts Institute of Technology (PhD, Biological Engineering); Rice University (B.S., Bioengineering).
Founder mafias
Massachusetts Institute of Technology mafia1,220
Also came through, then founded or led a company.
Elad GilPhDFounded Brain Co. +1Hemant TanejaM.Eng.Founded Hippocratic AINat FriedmanBachelor of ScienceFounded XamarinBrad FeldS.B.Founded TechstarsMatt HuangB.S.Founded Paradigm +1Delian AsparouhovDropoutFounded Nightingale +1
+ 1,213 more
Rice University mafia103
Also came through, then founded or led a company.
Brian ArmstrongBachelor’s DegreeFounded Coinbase +1Chris GibsonBachelor of Science (B.S.)Founded Recursion +2Dan WallaceBSMEFounded Versa Vascular +2Suman KhatiwadaPh.D.Founded Syzygy Plasmonics +2Eric M. ElfmanMBAFounded Onit +2Web SmithStudy: RussianFounded Mizzen+Main +1
+ 96 more
Quralis mafia5
Also came through, then founded or led a company.
SV Health Investors mafia4
Also came through, then founded or led a company.
Sudo Bio mafia3
Also came through, then founded or led a company.
Same school
Also attended Massachusetts Institute of Technology2,000
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,994 more
Also attended Rice University212
Brian ArmstrongCo-founder & CEO of CoinbaseAbigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesEdi DanalacheSenior Associate at Scale Venture PartnersJim BridenstineManaging Partner, Artemis Group at Cortado VenturesNicolette HoffmannSenior Associate at JMI EquityPatrick OkoraforDirector of Finance at Mercury Fund
+ 206 more
Shared employers
Also worked at Transposon Therapeutics, Inc.2
Also worked at JDRF T1D Fund16
Clay RowlandInvestment Associate at Mission BiocapitalSean O'ConnorPrincipal at Longwood FundValerie SuAssociate at JDRF T1D FundDaniel FlickerSenior Associate at JDRF T1D FundSylvia TobéManaging Director at JDRF T1D FundMorgan JanesAssociate at JDRF T1D Fund
+ 10 more
